Patent US5099019A successfully refreshed from Google Patents.
US5099019A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Amines useful in producing pharmaceutically active CNS compounds
Assignee: Pharmacia and Upjohn Co
•
Filing: 1988-08-08
•
Granted: 1992-03-24
•
Expires: 2008-08-08
Abstract
Abstract Disclosed are Δ 9 (11) -steroids (VI) and amino substituted steroids (XI) which contain an amino group attached to the terminal carbon atom of the C 17 -side chain, more particularly amino steroids (Ia and Ib), aromatic steroids (II), Δ 16 -steroids (IIIa and IIIb), reduced A-ring steroids (IV), Δ 17 (20) -steroids (Va and Vb) and Δ 9 (11) -steroids (VI) which are useful as pharmaceutical agents for treating a number of conditions.
Inventors
- 👤 John M. McCall
- 👤 Donald E. Ayer
- 👤 E. Jonathan Jacobsen
- 👤 Frederick J. VanDoornik
- 👤 John R. Palmer
- 👤 Harold A. Karnes
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 15:02
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/72; C07D213/74; C07D213/62; C07D213/63; C07D213/65; C07D239/00; C07D239/02; C07D239/24; C07D239/28; C07D239/46; C07D239/50; C07D249/00; C07D249/02; C07D249/08; C07D249/10; C07D249/14; C07D251/00; C07D251/02; C07D251/12; C07D251/26; C07D251/40; C07D251/54; C07D251/70; C07D295/00; C07D295/04; C07D295/12; C07D295/135; C07D307/00; C07D307/02; C07D307/34; C07D307/56; C07D307/68; C07D333/00; C07D333/50; C07D333/52; C07D333/62; C07D333/66; C07D401/00; C07D401/14; C07J; C07J21/00; C07J21/005; C07J21/006; C07J3/00; C07J3/005; C07J31/00; C07J31/006; C07J41/00; C07J41/0033; C07J41/005; C07J43/00; C07J43/003; C07J5/00; C07J5/0046; C07J5/0061; C07J5/0069; C07J5/0076; C07J7/00; C07J7/008; C07J7/0085
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
25 words
An amine selected from the group consisting of 4-[2,6-bis(diethylamino)-4-pyrimidinyl]piperazine, 4-[6-amino-4-(diethylamino)-2-pyrimidinyl]piperazine, 4-[2,6-bis(dimethylamino)-4-pyrimidinyl]piperazine, 4-[2-(diethylamino)-6-(1-pyrrolidinyl)-4-pyrimidinyl]piperazine, 4-[2,6-bis(4-methyl-1-piperazinyl)-4-pyrimidinyl]piperazine, 4-[2-(diethylamino)-6-(4-methyl-1-piperazinyl)-4-pyrimidinyl]-piperazine, 4-[2-(diethylamino)-6-(1-piperidinyl)-4-pyrimidinyl]piperazine, 4-[2,6-bis(1-pyrrolidinyl)-4-pyrimidinyl]piperazine, 4-[2,6-bis(4-morpholino)-4-pyrimidinyl]piperazine, 4-[2,6-bis(allylamino)-4-pyrimidinyl]piperazine, 4-[4,6-bis(diethylamino)-2-pyrimidinyl]piperazine, 4-[2-[4-[2,6-bis(1-pyrrolidinyl)-4-pyrimidinyl]-1-piperazinyl]-ethyl]piperazine and salts and hydrates thereof.
Claim 2
Dependent Claim
25 words
An amine selected from the group consisting of 4-[2,6-bis(diethylamino)-4-pyrimidinyl]piperazine, 4-[6-amino-4-(diethylamino)-2-pyrimidinyl]piperazine, 4-[2,6-bis(dimethylamino)-4-pyrimidinyl]piperazine, 4-[2-(diethylamino)-6-(1-pyrrolidinyl)-4-pyrimidinyl]piperazine, 4-[2,6-bis(4-methyl-1-piperazinyl)-4-pyrimidinyl]piperazine, 4-[2-(diethylamino)-6-(4-methyl-1-piperazinyl)-4-pyrimidinyl]-piperazine, 4-[2-(diethylamino)-6-(1-piperidinyl)-4-pyrimidinyl]piperazine, 4-[2,6-bis(1-pyrrolidinyl)-4-pyrimidinyl]piperazine, 4-[2,6-bis(4-morpholino)-4-pyrimidinyl]piperazine, 4-[2,6-bis(allylamino)-4-pyrimidinyl]piperazine, 4-[4,6-bis(diethylamino)-2-pyrimidinyl]piperazine, 4-[2-[4-[2,6-bis(1-pyrrolidinyl)-4-pyrimidinyl]-1-piperazinyl]-ethyl]piperazine and salts and hydrates thereof.
Claim 3
Dependent Claim
17 words
An amine according to claim 1 which is selected from the group consisting of 4-[2,6-bis(1-pyrrolidinyl)-4-pyrimidinyl]piperazine, 4-[2,6-bis(4-morpholino)-4-pyrimidinyl]piperazine, 4-[4,6-bis(diethylamino)-2-pyrimidinyl]piperazine.
Claim 4
Dependent Claim
9 words
An amine according to claim 2 which is 4-[2,6-bis(1-pyrrolidinyl)-4-pyrimidinyl]piperazine.
References Cited (Backward Citations)
GB594146A
Cited
US2665274A
Cited
US2920999A
Cited
GB954146A
Cited
AT249883B
Cited
FR90805E
Cited
US3144446A
Cited
US3523942A
Cited
US3539687A
Cited
FR7253M
Cited
US3856956A
Cited
US3455968A
Cited
FR7031M
Cited
US3558608A
Cited
US3697509A
Cited
US3705150A
Cited
US3983111A
Cited
US3998829A
Cited
CA979894A
Cited
US4013688A
Cited
US3936464A
Cited
US4076737A
Cited
US4101545A
Cited
US4041055A
Cited
US4192871A
Cited
US4191759A
Cited
US4377584A
Cited
US4336200A
Cited
JPS6043068B2
Cited
EP0049683A2
Cited
US4381307A
Cited
US4421753A
Cited
US4492696A
Cited
DE3322120A1
Cited
US4524134A
Cited
US4409223A
Cited
US4456602A
Cited
US4532240A
Cited
GB2136293A
Cited
US4500461A
Cited
US4885296A
Cited
US4980350A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-03-24 | 1995-09-23 | 1996-03-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-03-24 | 1999-09-23 | 2000-03-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-03-24 | 2003-09-23 | 2004-03-24 | $7700.00 | Window Closed / Lapsed |